FI60711C - Foerfarande foer framstaellning av terapeutiskt anvaendbara 5,5-dimetyl-8-(p-fluorfenylalkyl)-10-hydroxi-2-(2-propynyl)-1,2,3,4-tetrahydro-5h-bensopyrano (4,3-c) pyridiner - Google Patents
Foerfarande foer framstaellning av terapeutiskt anvaendbara 5,5-dimetyl-8-(p-fluorfenylalkyl)-10-hydroxi-2-(2-propynyl)-1,2,3,4-tetrahydro-5h-bensopyrano (4,3-c) pyridiner Download PDFInfo
- Publication number
- FI60711C FI60711C FI920/74A FI92074A FI60711C FI 60711 C FI60711 C FI 60711C FI 920/74 A FI920/74 A FI 920/74A FI 92074 A FI92074 A FI 92074A FI 60711 C FI60711 C FI 60711C
- Authority
- FI
- Finland
- Prior art keywords
- formula
- reacted
- fluorophenyl
- tetrahydro
- hydroxy
- Prior art date
Links
- -1 2-PROPYNYL Chemical class 0.000 title claims description 14
- 239000002253 acid Substances 0.000 title claims description 6
- 238000000034 method Methods 0.000 title claims description 5
- 230000001225 therapeutic effect Effects 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- YORCIIVHUBAYBQ-UHFFFAOYSA-N propargyl bromide Chemical compound BrCC#C YORCIIVHUBAYBQ-UHFFFAOYSA-N 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 6
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 6
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 229910000042 hydrogen bromide Inorganic materials 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- 150000003222 pyridines Chemical class 0.000 claims description 3
- ORZVNFUWSBVLLD-UHFFFAOYSA-N 1-benzylchromeno[3,2-b]pyridine Chemical compound C(C1=CC=CC=C1)N1C=CC=C2C1=CC1=C(O2)C=CC=C1 ORZVNFUWSBVLLD-UHFFFAOYSA-N 0.000 claims description 2
- 150000004820 halides Chemical class 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- LNBMZFHIYRDKNS-UHFFFAOYSA-N 2,2-dimethoxy-1-phenylethanone Chemical compound COC(OC)C(=O)C1=CC=CC=C1 LNBMZFHIYRDKNS-UHFFFAOYSA-N 0.000 claims 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000000932 sedative agent Substances 0.000 description 3
- 230000001624 sedative effect Effects 0.000 description 3
- YJKHOUIVWKQRSL-UHFFFAOYSA-N 1-(3,5-dimethoxyphenyl)ethanone Chemical compound COC1=CC(OC)=CC(C(C)=O)=C1 YJKHOUIVWKQRSL-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 229940125723 sedative agent Drugs 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- DKSZLDSPXIWGFO-BLOJGBSASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O.OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC DKSZLDSPXIWGFO-BLOJGBSASA-N 0.000 description 1
- FLRUNCJXOVYWDH-UHFFFAOYSA-N 1-(2-bromoethyl)-4-fluorobenzene Chemical compound FC1=CC=C(CCBr)C=C1 FLRUNCJXOVYWDH-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- KFRWBBFTOLGVSB-UHFFFAOYSA-N CCCC(C1=CC=C(C=C1)F)C2=CC(=CC(=C2)OC)OC Chemical compound CCCC(C1=CC=C(C=C1)F)C2=CC(=CC(=C2)OC)OC KFRWBBFTOLGVSB-UHFFFAOYSA-N 0.000 description 1
- XSRWMYORWAQSNQ-UHFFFAOYSA-N FNCl Chemical compound FNCl XSRWMYORWAQSNQ-UHFFFAOYSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 101000913968 Ipomoea purpurea Chalcone synthase C Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 101000907988 Petunia hybrida Chalcone-flavanone isomerase C Proteins 0.000 description 1
- 230000001384 anti-glaucoma Effects 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229940125714 antidiarrheal agent Drugs 0.000 description 1
- 239000003793 antidiarrheal agent Substances 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229960004415 codeine phosphate Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- SDIXRDNYIMOKSG-UHFFFAOYSA-L disodium methyl arsenate Chemical compound [Na+].[Na+].C[As]([O-])([O-])=O SDIXRDNYIMOKSG-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- VOKSWYLNZZRQPF-GDIGMMSISA-N pentazocine Chemical compound C1C2=CC=C(O)C=C2[C@@]2(C)[C@@H](C)[C@@H]1N(CC=C(C)C)CC2 VOKSWYLNZZRQPF-GDIGMMSISA-N 0.000 description 1
- 229960005301 pentazocine Drugs 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000004799 sedative–hypnotic effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
- C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/205—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
- C07C43/2055—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring containing more than one ether bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34594273A | 1973-04-02 | 1973-04-02 | |
US34594273 | 1973-04-02 | ||
US44203274 | 1974-02-13 | ||
US05/442,032 US3932432A (en) | 1973-04-02 | 1974-02-13 | Alkylphenyl benzopyranopyridines |
Publications (2)
Publication Number | Publication Date |
---|---|
FI60711B FI60711B (fi) | 1981-11-30 |
FI60711C true FI60711C (fi) | 1982-03-10 |
Family
ID=26994621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI920/74A FI60711C (fi) | 1973-04-02 | 1974-03-26 | Foerfarande foer framstaellning av terapeutiskt anvaendbara 5,5-dimetyl-8-(p-fluorfenylalkyl)-10-hydroxi-2-(2-propynyl)-1,2,3,4-tetrahydro-5h-bensopyrano (4,3-c) pyridiner |
Country Status (13)
Country | Link |
---|---|
US (1) | US3932432A (no) |
JP (1) | JPS5632995B2 (no) |
CA (1) | CA1020559A (no) |
CH (1) | CH593288A5 (no) |
DE (1) | DE2415698A1 (no) |
DK (1) | DK144656C (no) |
FI (1) | FI60711C (no) |
FR (1) | FR2223041B1 (no) |
GB (1) | GB1438423A (no) |
NL (1) | NL7404244A (no) |
NO (1) | NO139961C (no) |
PH (1) | PH10450A (no) |
SE (2) | SE410969B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4247557A (en) * | 1976-08-04 | 1981-01-27 | Abbott Laboratories | Benzopyranopyridines as antiglaucoma agents |
US4136183A (en) * | 1976-08-04 | 1979-01-23 | Abbott Laboratories | Benzopyranopyridines as antiglaucoma agents |
JPS5392798A (en) * | 1977-01-21 | 1978-08-15 | Abbott Lab | 2*88substituted 100hydroxyy5*55 dimethyll1*2*3*44tetrahydroo5hh *1*benzopyrano*4*33c*pyridines |
US4137232A (en) * | 1978-04-19 | 1979-01-30 | Abbott Laboratories | 2,8-Disubstituted-10-hydroxy-5,5-dimethyl-1,2,3,4-tetrahydro-5H -[1]benzopyrano[4,3-c]pyridine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3878219A (en) * | 1973-07-13 | 1975-04-15 | Abbott Lab | 5H-{8 1{9 benzopyrano{8 3,4-d{9 pyridines |
-
1974
- 1974-02-13 US US05/442,032 patent/US3932432A/en not_active Expired - Lifetime
- 1974-03-26 FI FI920/74A patent/FI60711C/fi active
- 1974-03-28 NL NL7404244A patent/NL7404244A/xx not_active Application Discontinuation
- 1974-03-29 FR FR7411149A patent/FR2223041B1/fr not_active Expired
- 1974-03-29 NO NO741141A patent/NO139961C/no unknown
- 1974-04-01 PH PH15682A patent/PH10450A/en unknown
- 1974-04-01 SE SE7404387A patent/SE410969B/xx unknown
- 1974-04-01 CA CA196,454A patent/CA1020559A/en not_active Expired
- 1974-04-01 GB GB1440674A patent/GB1438423A/en not_active Expired
- 1974-04-01 DE DE2415698A patent/DE2415698A1/de not_active Ceased
- 1974-04-02 CH CH461874A patent/CH593288A5/xx not_active IP Right Cessation
- 1974-04-02 DK DK183374A patent/DK144656C/da not_active IP Right Cessation
- 1974-04-02 JP JP3671874A patent/JPS5632995B2/ja not_active Expired
-
1976
- 1976-05-20 SE SE7605758A patent/SE425786B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
PH10450A (en) | 1977-03-31 |
DK144656C (da) | 1982-10-04 |
FI60711B (fi) | 1981-11-30 |
FR2223041B1 (no) | 1977-07-01 |
CA1020559A (en) | 1977-11-08 |
GB1438423A (en) | 1976-06-09 |
AU6664874A (en) | 1975-09-18 |
CH593288A5 (no) | 1977-11-30 |
SE425786B (sv) | 1982-11-08 |
SE7605758L (sv) | 1976-05-21 |
US3932432A (en) | 1976-01-13 |
NO139961C (no) | 1979-06-13 |
NO741141L (no) | 1974-10-03 |
JPS5632995B2 (no) | 1981-07-31 |
NO139961B (no) | 1979-03-05 |
DK144656B (da) | 1982-05-03 |
SE410969B (sv) | 1979-11-19 |
FR2223041A1 (no) | 1974-10-25 |
NL7404244A (no) | 1974-10-04 |
DE2415698A1 (de) | 1974-10-10 |
JPS5062999A (no) | 1975-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU668107B2 (en) | Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs | |
DD204698A5 (de) | Verfahren zur herstellung von 3,4-dihydro-5h-2,3-benzodiazepin derivaten | |
ES2928904T3 (es) | Moduladores de ROR-gamma | |
IE840826L (en) | Furo-pyridines | |
FI67686C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenetanolaminderivat | |
JP3462165B2 (ja) | 神経筋遮断剤 | |
US8450318B2 (en) | Method to treat infections using anti-infective agents | |
US3205136A (en) | Antidepressant phenyloxyalkylamines | |
FI60711C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 5,5-dimetyl-8-(p-fluorfenylalkyl)-10-hydroxi-2-(2-propynyl)-1,2,3,4-tetrahydro-5h-bensopyrano (4,3-c) pyridiner | |
IL123916A (en) | History [(-3 Alkoxy - Paneoxy) - Ethyl] dialkylamine and their use as local anesthetics | |
KR0154529B1 (ko) | 4-벤질-5-페닐-2,4-디히드로-3h-1,2,4-트리아졸-3-온의 진경제로서의 용도 | |
AT391320B (de) | Piperazincarbonsaeure, ihre herstellung und diese enthaltende arzneimittel | |
PL123910B1 (en) | Method of manufacture of novel derivatives of di-o-n-alkylglycerol | |
US4439619A (en) | Fluorinated pentene diamine derivatives | |
JP2520590B2 (ja) | カテコ―ルアミン化合物のe/o―ホスフェ―トエステル,その製法およびそれを含有する薬剤組成物 | |
KR20000070507A (ko) | 하이드로퀴논 유도체 | |
WO2022125614A1 (en) | Phosphonates as inhibitors of enpp1 and cdnp | |
KR900006132B1 (ko) | 젬-디할로-1,8-디아미노-4-아자-옥탄 및 이의 제조방법 | |
US4337252A (en) | 1-Phenyl-4-morpholino-1-buten-3-01 derivatives, compositions and use | |
DE3434948A1 (de) | Vinyltetrazolylphenyl-derivate, ihre herstellung und verwendung | |
US3657441A (en) | Method of inhibiting the formation of phenylethanolamine n-methyl transferase with imidazoles | |
US4313956A (en) | Novel sypathomimetic amine prodrugs | |
KR20010012764A (ko) | 2,3-디히드로벤조푸란 유도체 | |
WO1994006762A1 (en) | Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors | |
US3646010A (en) | Spiroazetidine-ethanoanthracenes |